Compare
Stereotaxis, Inc. vs Conmed Corp vs iTonic Holdings Ltd vs Medtronic plc
| Latest fiscal year | Stereotaxis, Inc. STXS | Conmed Corp CNMD | iTonic Holdings Ltd ITOC | Medtronic plc MDT |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2026-04-24 |
| Revenue | $32.38M | $1.37B | $523.0K | $36.36B |
| Revenue growth (YoY) | +20.3% | +5.2% | +16.7% | +8.4% |
| Gross margin | 52.7% | 54.6% | 62.6% | 65.0% (computed) |
| Operating margin | -68.3% | 7.5% | -991.7% | 17.8% |
| Net margin | -66.8% | 3.4% | -974.7% | 13.2% |
| Net income | -$21.64M | $47.05M | -$5.10M | $4.80B |
| EPS (Diluted) | -$0.25 | $1.51 | -$0.32 | $3.73 |
| Operating cash flow | -$13.69M | $170.69M | -$3.23M | $7.33B |
| Free cash flow | -$13.78M | $150.88M | -$3.24M | $5.43B |
| Cash & equivalents | $13.42M | n/a | $1.49M | $1.95B |
| Total assets | $52.25M | $2.33B | $9.10M | $93.03B |
| Total liabilities | $33.53M | $1.29B | $969.8K | $42.96B |
| Shareholders' equity | $13.48M | $1.03B | $6.12M | $49.46B |
| Return on year-end equity | -160.5% | 4.6% | -83.3% | 9.7% |
| Shares outstanding | n/a | n/a | n/a | 1.28B |
Revenue, most recent five fiscal years
| Fiscal year | Stereotaxis, Inc. | Conmed Corp | iTonic Holdings Ltd | Medtronic plc |
|---|---|---|---|---|
| Latest | $32.38M Ended 2025-12-31 | $1.37B Ended 2025-12-31 | $523.0K Ended 2025-12-31 | $36.36B Ended 2026-04-24 |
| 1 year earlier | $26.92M Ended 2024-12-31 | $1.31B Ended 2024-12-31 | $448.2K Ended 2024-12-31 | $33.54B Ended 2025-04-25 |
| 2 years earlier | $26.77M Ended 2023-12-31 | $1.24B Ended 2023-12-31 | $628.6K Ended 2023-12-31 | $32.36B Ended 2024-04-26 |
| 3 years earlier | $28.15M Ended 2022-12-31 | $1.05B Ended 2022-12-31 | $679.8K Ended 2022-12-31 | $31.23B Ended 2023-04-28 |
| 4 years earlier | $35.02M Ended 2021-12-31 | $1.01B Ended 2021-12-31 | n/a | $31.69B Ended 2022-04-29 |